Search scope:
排序: Display mode:
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 204-211 doi: 10.1007/s11684-012-0202-x
We evaluated the outcomes of chronic myeloid leukemia (CML) patients in three clinical phases, namely, chronic (CP), accelerated (AP), and blast (BP) phases, receiving imatinib treatment.
Keywords: imatinib chronic myeloid leukemia complete cytogenetic response
Lanping Xu,Huanling Zhu,Jianda Hu,Depei Wu,Hao Jiang,Qian Jiang,Xiaojun Huang
Frontiers of Medicine 2015, Volume 9, Issue 3, Pages 304-311 doi: 10.1007/s11684-015-0400-4
In the tyrosine kinase inhibitor (TKI) era, imatinib is the first-line therapy for patients with chronicmyeloid leukemia (CML) in chronic or accelerated phase.
Keywords: chronic myeloid leukemia imatinib dasatinib nilotinib allogeneic hematopoietic stem cell transplantation
Xiaojun Huang, Qian Jiang, Jianda Hu, Jianyong Li, Jie Jin, Fanyi Meng, Zhixiang Shen, Ting Liu, Depei Wu, Jianmin Wang, Jianxiang Wang
Frontiers of Medicine 2019, Volume 13, Issue 3, Pages 344-353 doi: 10.1007/s11684-018-0639-7
Keywords: chronic myeloid leukemia (CML) dasatinib tyrosine kinase inhibitor long-term follow-up
Molecular pathogenesis of acute myeloid leukemia: A diverse disease with new perspectives
Felicitas THOL, Arnold GANSER
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 356-362 doi: 10.1007/s11684-010-0220-5
Keywords: acute myeloid leukemia mutations risk stratification
FGF13 suppresses acute myeloid leukemia by regulating bone marrow niches
Frontiers of Medicine 2022, Volume 16, Issue 6, Pages 896-908 doi: 10.1007/s11684-022-0944-z
Keywords: acute myeloid leukemia FGF13 prognosis immune-related genes bone marrow niches
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 685-698 doi: 10.1007/s11684-022-0942-1
Keywords: acute myeloid leukemia acyl-CoA synthetase long chain family member 5 Wnt3a palmitoylation ABT-199
Frontiers of Medicine 2022, Volume 16, Issue 4, Pages 627-636 doi: 10.1007/s11684-020-0815-4
Keywords: RUNX1 gene mutation acute myeloid leukemia transcriptional repression DNA methylation
Zhan Su, Fengyu Wu, Weiyu Hu, Xiaodan Liu, Shaoling Wu, Xianqi Feng, Zhongguang Cui, Jie Yang, Zhenguang Wang, Hongzai Guan, Hongguo Zhao, Wei Wang, Chunting Zhao, Jun Peng
Frontiers of Medicine 2017, Volume 11, Issue 3, Pages 440-444 doi: 10.1007/s11684-017-0523-x
Philadelphia chromosome-positive acute myeloid leukemia is controversial and difficult to distinguishfrom the blast phase of chronic myeloid leukemia.As a myeloid neoplasm, rare cases of this leukemia manifest multiple soft-tissue tumors or bone lyticfusion gene together with complex chromosome abnormalities, a diagnosis of Philadelphia-positive acute myeloidleukemia was made, although the type (de novo or blast crisis) remained unclear.
Keywords: Philadelphia chromosome acute myeloid leukemia mass osteolysis positron emission tomography
Meng Lv, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang, Xiaodong Mo
Frontiers of Medicine 2019, Volume 13, Issue 6, Pages 667-679 doi: 10.1007/s11684-019-0702-z
Keywords: acute graft-versus-host disease chronic graft-versus-host disease National Institutes of Health consensuscriteria acute myeloid leukemia anti-thymocyte globulin
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 701-710 doi: 10.1007/s11684-020-0763-z
Keywords: acute myeloid leukemia CAR T immunotherapy
Bingshan Liu, Roshni Narurkar, Madhura Hanmantgad, Wahib Zafar, Yongping Song, Delong Liu
Frontiers of Medicine 2018, Volume 12, Issue 5, Pages 593-599 doi: 10.1007/s11684-018-0635-y
Keywords: venetoclax cytarabine AML leukemia
The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia
Jessica Fredericks, Ruibao Ren
Frontiers of Medicine 2013, Volume 7, Issue 4, Pages 452-461 doi: 10.1007/s11684-013-0304-0
BCR/ABL is the causative agent of chronic myelogenous leukemia (CML).
Keywords: BCR/ABL chronic myelogenous leukemia (CML) RAS RAL
Yuting Tan,Han Liu,Saijuan Chen
Frontiers of Medicine 2015, Volume 9, Issue 4, Pages 412-420 doi: 10.1007/s11684-015-0423-x
Genetic mutations are considered to drive the development of acute myeloid leukemia (AML).mutations alone may only transform hematopoietic stem cells into pre-LSCs without causing the full-blown leukemia
Keywords: preleukemic stem cell acute myeloid leukemia relapse DNMT3A
Xiaoxiao Chen, Yanjing Tang, Jing Chen, Ru Chen, Longjun Gu, Huiliang Xue, Ci Pan, Jingyan Tang, Shuhong Shen
Frontiers of Medicine 2019, Volume 13, Issue 3, Pages 378-387 doi: 10.1007/s11684-018-0658-4
Keywords: homoharringtonine acute myeloid leukemia pediatrics
Mutation profiling of 16 candidate genes in
Yang Zhang, Fang Wang, Xue Chen, Wenjing Liu, Jiancheng Fang, Mingyu Wang, Wen Teng, Panxiang Cao, Hongxing Liu
Frontiers of Medicine 2019, Volume 13, Issue 2, Pages 229-237 doi: 10.1007/s11684-018-0616-1
Title Author Date Type Operation
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Journal Article
allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronicmyelogenous leukemia in the accelerated phase
Lanping Xu,Huanling Zhu,Jianda Hu,Depei Wu,Hao Jiang,Qian Jiang,Xiaojun Huang
Journal Article
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving
Xiaojun Huang, Qian Jiang, Jianda Hu, Jianyong Li, Jie Jin, Fanyi Meng, Zhixiang Shen, Ting Liu, Depei Wu, Jianmin Wang, Jianxiang Wang
Journal Article
Molecular pathogenesis of acute myeloid leukemia: A diverse disease with new perspectives
Felicitas THOL, Arnold GANSER
Journal Article
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/-catenin signaling
Journal Article
expression pattern of mutations coordinated by target repression and promoter hypermethylation in acute myeloidleukemia
Journal Article
Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of
Zhan Su, Fengyu Wu, Weiyu Hu, Xiaodan Liu, Shaoling Wu, Xianqi Feng, Zhongguang Cui, Jie Yang, Zhenguang Wang, Hongzai Guan, Hongguo Zhao, Wei Wang, Chunting Zhao, Jun Peng
Journal Article
Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidenticalhematopoietic stem cell transplantation in acute myeloid leukemia
Meng Lv, Xiaohui Zhang, Lanping Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuhong Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Kaiyan Liu, Xiaojun Huang, Xiaodong Mo
Journal Article
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Journal Article
Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloidleukemia: a case report
Bingshan Liu, Roshni Narurkar, Madhura Hanmantgad, Wahib Zafar, Yongping Song, Delong Liu
Journal Article
The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia
Jessica Fredericks, Ruibao Ren
Journal Article
methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia
Yuting Tan,Han Liu,Saijuan Chen
Journal Article
a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloidleukemia
Xiaoxiao Chen, Yanjing Tang, Jing Chen, Ru Chen, Longjun Gu, Huiliang Xue, Ci Pan, Jingyan Tang, Shuhong Shen
Journal Article